Evidence map›Paper›PMID 34046188›Full record

ArticleFuture science OA2021

Survival and glycemic control in patients with co-existing squamous cell carcinoma and diabetes mellitus.

Sophia A Ederaine, Johanny Lopez Dominguez, Jamison A Harvey, Aaron R Mangold, Curtiss B Cook, Heidi Kosiorek, Matthew Buras, Kyle Coppola, Nina J Karlin

Open access · goldAbstract read
In one paragraph

Article in Future science OA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Impact of diabetes mellitus in cancer.The Indian journal of medical research · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sophia A EderaineMayo Clinic Alix School of Medicine, Scottsdale, AZ 85259, USA.
Johanny Lopez DominguezMayo Clinic Alix School of Medicine, Scottsdale, AZ 85259, USA.ORCID https://orcid.org/0000-0002-1688-984X
Jamison A HarveyDepartment of Dermatology, Mayo Clinic, Scottsdale, AZ 85259, USA.ORCID https://orcid.org/0000-0003-1608-4635
Aaron R MangoldDepartment of Dermatology, Mayo Clinic, Scottsdale, AZ 85259, USA.ORCID https://orcid.org/0000-0001-6873-1705
Curtiss B CookDivision of Endocrinology, Mayo Clinic, Scottsdale, AZ 85259, USA.
Heidi KosiorekDepartment of Health Sciences Research, Mayo Clinic, Scottsdale, AZ 85259, USA.
Matthew BurasDepartment of Cancer Quality Program, Mayo Clinic, Scottsdale, AZ 85259, USA.
Kyle CoppolaDepartment of Information Technology, Mayo Clinic, Phoenix, AZ 85054, USA.
Nina J KarlinDivision of Hematology & Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ 85054, USA.ORCID https://orcid.org/0000-0001-9790-0379
Mayo Clinic in Arizona · USMayo Clinic Hospital · USWinnMed · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis study examined the impact of diabetes mellitus (DM) on survival in squamous cell carcinoma (SCC) patients, and the impact of SCC on glycemic control. MATERIALS &

methodsPatients with newly diagnosed SCC with and without DM were matched 1:1 (2007-2017). Overall survival and recurrence-free survival were estimated using the Kaplan-Meier method. Hemoglobin A

resultsHbA

conclusionThe presence of co-existing DM adversely impacted survival in patients with SCC. SCC did not affect glycemic control.

Indexed as

cancerdiabetesendocrinologyglycemic controloutcomes researchsquamous cell carcinoma

Identifiers

PMID34046188
PMCPMC8147738
OpenAlexW3126724529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.